Sidebar

04
Mon, Jul

New drug PLX4032 targets genetic mutation in 60% of people with melanoma, patients saw their tumor shrink - Nightly News (3 videos)

Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Doctors are experimenting with a promising new approach to treating an all-too-common and potentially deadly cancer.

- more than 80% saw their tumor shrink.
- PLX4032 targets a genetic mutation that appears in about 60% of people with melanoma.
- another drug called ipilimumab appears to cure 20%-30% of patients by stimulating the immune system.

 

New hope for melanoma patients
http://www.msnbc.msn.com/id/34276015/vp/38855575#38856751

Visit msnbc.com for breaking news, world news, and news about the economy


NBC News (video)

A new drug shows great promise in fighting melanoma.

- while the drug is affective the cancer often returned after a year sparking other research to combine other drugs.


Drug shrinks melanoma tumors
http://www.msnbc.msn.com/id/21134540/vp/38854903#38854903

Visit msnbc.com for breaking news, world news, and news about the economy

 

Nightly News (video)

Emily Black, a melanoma patient describes her treatments, the side effects, and how surprised she was when her medication began to work.

Melanoma patient 'taking life one day at a time'
http://www.msnbc.msn.com/id/34276015/vp/38855575#38855575

Visit msnbc.com for breaking news, world news, and news about the economy